{"summary": "genes encoding truncated nucleocapsid (N) and spike (S) proteins of SARSCoV were cloned into the expression vector pQE30 and fusionally expressed in Escherichia coli M15. the fusion protein was injected into 6-week-old BALB/c mice and a neutralization test as well as a T-cell analysis was performed. the truncated fusion protein is a suitable immunodiagnostic antigen and vaccine candidate. the truncated fusion protein is a suitable immunodiagnostic antigen and vaccine candidate. the truncated fusion protein is a suitable immunodiagnostic antigen and vaccine candidate. pQE30 vector was purchased from Qiagen GmbH, Hilden, Germany. Escherichia coli M15 was used as host strain for the vector. all work with infectious virus was performed in a biosafety level 3 laboratory. all restriction enzymes and ligases were purchased from TaKaRa biotechnology Co., Ltd. the presence of target genes in the recombinant plasmids was verified by gene-specific PCR and sequence analysis. ccc ctgcagtta tgc ctg agt tga atc agc aga -3' 246 229E-tNf-925 5'- ccc gtc aaa gtt tac ttc atc aat tat -3' 363 OC43-tNr-1347 5'- ccc aagctttt the transformed bacteria were induced with 2.0 mM IPTG at 37\u00b0C. inclusion bodies containing recombinant proteins were serially extracted with 2 M urea and then dissolved in 8 M urea. it was then subjected to purification by means of a Ni-NTA Affinity Chromatography Purification Kit according to manual (Qiagen GmbH). 460 serum samples from SARS convalescents were collected in 301 Hospital (Beijing, China) and 302 Hospital (Beijing, China) all sera were tested positive by the SARSCoV lysate ELISA IgG Kit (Beijing BGI-GBI Biotech Corp.) immunoblot analysis was performed using the mini-protein 3 Electrophoresis System (BIO-RAD) the stacking gel and separation gel contained 5% and 15% acrylamide, respectively. electrophoresis was carried out at a constant voltage of 120 V for 180 min. mouse sera were then tested against each of the recombinant proteins. peroxidase-conjugated goat anti-mice IgG washed five times with the PBS/Tween-20 buffer. the plates were incubated at 37\u00b0C for 30 min, then washed five times with the PBS/Tween-20 buffer. the cut-off values for IgG were 0.16 (three N proteins), 0.12 (truncated S protein), 0.14 (three truncated N proteins), 0.12 (truncated Approximately 50 L of SARSCoV (BJ01 strain) (400 TCID50/100 L) was mixed with an equal volume of diluted serum and incubated at 35\u00b0C for 1 h. then 50 uL of the mixture and 50 L of DMEM containing 5% inactivated fetal calf serum were added onto a veroE6 cell monolayer in triplicate. cross-reactivity among viruses and recombinant proteins was tested by incuba four BALB/c mice in each group were killed on day 33 after immunization. their spleens were ground into single-cell suspensions in RPMI 1640 medium (Gibco) supplemented with 10% fetal calf serum. pellets were seeded in triplicates in flat-bottom 96-well microtiter plates. the optical densities at 570 nm (OD570) and at 630 nm (OD630) were measured. four BALB/c mice from each group, immunized as well as controls, were challenged intranasally with 104 TCID50 of the SARSCoV GD01 strain. a mixture of 200 M (each) deoxynucleoside triphosphate, 0.3 M (each) primer and 1 U of Taq polymerase (Takara) proteins were amplified by RT-PCR in a mixture of 200 M (each) deoxynucleoside triphosphate, 0.3 M (each) primer, 1 U of Taq polymerase (Takara) in 10 mM Tris-HCl buffer (pH tgg gct gat -3' 1167 229E-Nr-1170 5'- ccc gtcgactta gtt act cct ggt aag caa -3' 1344 OC43-Nr-1347 5'- ccc aagctttttta tat ttc tga ggt gtc ttc -3' 30 ggatccctc aag tat gat gaa aat ggt aca atc aca -3' 1251 SARS-tSr-2040 5'- gc ggtaccaga cat agt ata agc cac aat aga -3' a f and r signify forward and reverse primers, respectively. b underlined sequences indicate restriction sites: BamHI (ggat the purity of target proteins was determined by SDS-PAGE [18]. 460 serum samples from SARS convalescents were collected in 301 Hospital (Beijing, China) and 302 Hospital (Beijing, China) all seras were tested positive by the SARSCoV lysate ELISA IgG Kit. mouse sera against purified recombinant proteins SARSCoV N, HCoV OC43 N, HCoV 229E N (IFA dilution: 1:5120, 1:2560, 1:5120, respectively) 460 serum samples from SARS convalescents fulfilled the clinical WHO case definition of SARS. all sera were tested positive by the SARSCoV lysate ELISA IgG Kit (Beijing BGI-GBI 0.1 mL of purified recombinant fusion truncated S-N protein solution (100 g/mL) and PBS mixed with equal volume of paraffin oil. immunoblot analysis performed as described elsewhere. the plates were incubated at 37\u00b0C for 30 min and washed five times with the PBS/Tween-20 buffer. the plates were incubated at 37\u00b0C for 30 min and washed five times with the PBS/Tween-20 buffer before the addition of tetramethyl-benzidine (TMB/hydrogen peroxide substrate) heat-inactivated (55\u00b0C for 30 min) mouse immune serum was diluted tenfold. then serially diluted twofold to 1:2560 in DMEM (Gibco) containing 5% heat-inactivated fetal calf serum (56\u00b0C for 30 min). Approximately 50 L of SARSCoV (BJ01 strain) (400 TCID50/100 L) was mixed with an equal volume of diluted serum and incubated at 35\u00b0C electrophoresis was carried out at a constant voltage of 120 V for 180 min. the proteins were electroblotted onto nitrocellulose membranes. mouse sera were then tested against each of the recombinant proteins. the OD450/630 value was measured with a microtiter plate reader in triplicates. the cut-off values for IgG were 0.16 (three N proteins), 0.12 (truncated S protein), 0.14 (three truncated N proteins), 0.12 (truncated S-N protein), respectively. dilution of serum that completely prevented CPE in 50% of the wells was calculated according to the Reed Muench formula [22] cross-reactivity among different human coronaviruses was tested by incubation of SARSCoV-infected cells with mouse antisera against the two other human coronaviruses. four BALB/c mice in each group were killed on day 33 after immunization. their spleens were ground into single-cell suspensions in RPMI 1640 medium (Gibco) supplemented with 10% fetal calf serum. pellets were seeded in triplicates in flat-bottom microtiter plates. spleen lymphocyte immune response The proliferation of spleen lymphocytes was measured by colorimetric analysis described previously [23] four BALB/c mice in each group were killed after immunization and their spleens were ground into single-cell suspensions in RPMI 1640 medium (Gibco) supplemented with 10% fetal calf serum. lysis buffer containing 10% Triton-50% isopropanol-0.01 M hydrochloric acid was added to each well. the plates were incubated for 4 h at 37\u00b0C. the optical densities at 570 nm (OD570) and at 630 nm (OD630) were measured. the results showed 34 and 21 sera were tested positive by N proteins of HCoVOC43 and HCoV229E respectively. none of the sera were tested positive by both truncated N proteins of HCoVOC43 and HCoVOC43. all 460 SARS patients' sera were tested against all four antigens. only 3 samples were tested negative in the truncated S-N fusion protein assay. 62, 38 and 43 samples were tested negative in the truncated S protein, N protein and truncated N protein assays. serum titer of neutralizing antibodies against SARSCoV was 2.425 0.209 (Lg dilution SD) only mice antiserum against SARSCoV(BJ01) tests positive. the truncated S-N protein could induce T cell proliferation of mice immunized with the truncated fusion protein. significant differences were found between mice immunized with the truncated fusion protein and the controls (t test p = 0.0084 0.05). the mean of virus genome copy numbers are 20708 6202 (copies/g SD) per 1 gram lung tissue in the control group. virus loads in mice immunized with truncated S-N protein were below the limit of detection. ARSCoV infected cell using mouse anti-sera to recombinant N proteins of other two human Coronaviruses. A: Reacted with mouse anti-serum to HCoV229E N protein; B: Reacted with mouse anti-serum to HCoVOC43 N protein; D: Reacted with mouse serum from controls injected with PBS. all 460 SARS patients' sera were tested against all four antigens. only 3 samples were tested negative in the truncated S-N fusion protein assay. 62, 38 and 43 samples were tested negative in the truncated S protein, N protein and truncated N protein assays. truncated S-N protein 457 3 0 650 Specific humoral and cellular anti-SARSCoV immune responses to the truncated fusion protein Sera antibody tests showed the ability of the truncated S-N protein to induce the generation of SARS-specific antibodies in the immunized mice. nine to twelve days after injection, the specific Ig G antibody could be detected. the truncated S-N protein could induce T cell proliferation. significant differences were found between groups of mice immunized with recombinant protein or injected with PBS (T test P = 0.0084 0.05). the N protein of SARSCoV is 35\u201339% identical in amino acid sequence to that of HCoV 229E and HCoV NL63 and 47\u201350% identical in amino acid sequence to that of HCoVOC43 and HCoVHKU1. the C-terminal of the N protein (SARSCoV 321-422aa) has lower identity in amino acid sequence among these human coronaviruses. five positive sera to SARSCoV lysate antigen were all tested positive against SARSCoV N protein but negative against SARSCoV truncated N-S protein. only mice antiserum against SARSCoV (BJ01), HCoV229E and HCoVOC43 tested positive. truncated S-N fusion protein is a suitable diagnostic antigen for detection of SARSCoV antibodies. neutralizing epitopes showed that the receptor-binding region of the S protein plays an important role in virus infection [12,30,31]. a DNA vaccine study of SARSCoV has also shown that the S protein can induce protective immune responses to SARSCoV. studies of animal coronaviruses suggest both cellular and humoral immunity contribute to protection during persistent infection. potential candidate for the development of a SARS subunit vaccine. Competing interests The authors declare that they have no competing interests."}